Seer Inc Asset Turnover Ratio (SEER), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Seer Inc   (NASDAQ: SEER)
 

Seer Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Seer Inc 's asset turnover ratio sequentially decreased to 0.04 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 19 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3403, from total ranking in the first quarter 2026 at 3924.

Asset Turnover Ratio Definition



SEER Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change 100.06 % -21.63 % -14.18 % -14.67 % -16.09 %
Y / Y Revenue Change -0.29 % -51.19 % 3.14 % 4.37 % 13.91 %
Asset Turnover Ratio (TTM) 0.04 0.05 0.05 0.05 0.05
SEER's Total Ranking # 3403 # 3924 # 3534 # 3639 # 3701
Seq. Asset Change 137.08 % -8.09 % -4.06 % -4.3 % -7.13 %
Seq. Revenue Change 56.51 % -61.76 % 26.11 % 32.11 % -23.39 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 20
Healthcare Sector # 506
Overall Market # 3403

Asset Turnover Ratio Statistics
High Average Low
1.93 0.38 -0.09
(Dec 31 2014)   (Sep 30 2014)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
EBR Systems, Inc.  0.06 $ 6.446  Millions$ 105.295  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Grail Inc   0.06 $ 165.263  Millions$ 2,792.551  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Nexalin Technology Inc   0.05 $ 0.217  Millions$ 4.115  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Seer Inc   0.05 $ 14.377  Millions$ 283.365  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Tscan Therapeutics Inc   0.03 $ 7.111  Millions$ 216.114  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Ataibeckley Inc   0.02 $ 4.473  Millions$ 265.553  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.